InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp.verified

NVIV

Price:

$0.3207

Market Cap:

$995.92K

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.[Read more]

Industry

Biotechnology

IPO Date

2010-11-15

Stock Exchange

NASDAQ

Ticker

NVIV

The PE Ratio as of April 2024 (TTM) for InVivo Therapeutics Holdings Corp. (NVIV) is -0.10

According to InVivo Therapeutics Holdings Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -75.74% compared to the average of -0.40 of the last 4 quarters.

InVivo Therapeutics Holdings Corp. (NVIV) Historical PE Ratio (quarterly & annually)

How has NVIV PE Ratio performed in the past?

The mean historical PE Ratio of InVivo Therapeutics Holdings Corp. over the last ten years is -2.61. The current -0.10 PE Ratio has changed 274.57% with respect to the historical average. Over the past ten years (40 quarters), NVIV's PE Ratio was at its highest in in the June 2018 quarter at -0.06. The PE Ratio was at its lowest in in the September 2015 quarter at -25.21.

Quarterly (TTM)
Annual

Average

-2.61

Median

-1.24

Minimum

-6.35

Maximum

-0.16

InVivo Therapeutics Holdings Corp. (NVIV) PE Ratio by Quarter and Year

Discovering the peaks and valleys of InVivo Therapeutics Holdings Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 241.53%

Maximum Annual PE Ratio = -0.16

Minimum Annual Increase = -119.02%

Minimum Annual PE Ratio = -6.35

Quarterly (TTM)
Annual
YearPE RatioChange
2022-0.35-76.95%
2021-1.54149.22%
2020-0.62241.53%
2019-0.1810.97%
2018-0.16-82.82%
2017-0.95-82.93%
2016-5.56-2.81%
2015-5.72-9.97%
2014-6.3535.90%
2013-4.67-119.02%

InVivo Therapeutics Holdings Corp. (NVIV) Average PE Ratio

How has NVIV PE Ratio performed in the past?

The current PE Ratio of InVivo Therapeutics Holdings Corp. (NVIV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.84

5-year avg

-0.57

10-year avg

-2.61

InVivo Therapeutics Holdings Corp. (NVIV) PE Ratio vs. Peers

How is NVIV’s PE Ratio compared to its peers?

InVivo Therapeutics Holdings Corp.’s PE Ratio is greater than Virax Biolabs Group Limited (-0.18), greater than Blue Water Vaccines, Inc. (-0.17), less than Revelation Biosciences, Inc. (0.07), less than Hillstream BioPharma, Inc. (-0.00), greater than Kiora Pharmaceuticals, Inc. (-0.29), greater than NextCure, Inc. (-0.73), less than CytomX Therapeutics, Inc. (63.40), greater than Neoleukin Therapeutics, Inc. (-0.98), less than Spero Therapeutics, Inc. (3.13), greater than Assembly Biosciences, Inc. (-1.20), greater than Nutriband Inc. (-5.26), less than Quoin Pharmaceuticals, Ltd. (-0.08), greater than Longeveron Inc. (-0.20), greater than RenovoRx, Inc. (-1.29), greater than Anebulo Pharmaceuticals, Inc. (-6.63), greater than Rezolute, Inc. (-3.20), greater than HCW Biologics Inc. (-2.37), greater than Eliem Therapeutics, Inc. (-3.16), greater than Molecular Partners AG (-1.86), greater than Senti Biosciences, Inc. (-0.18), greater than SAB Biotherapeutics, Inc. (-0.62),

Build a custom stock screener for InVivo Therapeutics Holdings Corp. (NVIV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InVivo Therapeutics Holdings Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InVivo Therapeutics Holdings Corp. (NVIV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InVivo Therapeutics Holdings Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is InVivo Therapeutics Holdings Corp.'s PE Ratio?

How is the PE Ratio calculated for InVivo Therapeutics Holdings Corp. (NVIV)?

What is the highest PE Ratio for InVivo Therapeutics Holdings Corp. (NVIV)?

What is the 3-year average PE Ratio for InVivo Therapeutics Holdings Corp. (NVIV)?

What is the 5-year average PE Ratio for InVivo Therapeutics Holdings Corp. (NVIV)?

How does the current PE Ratio for InVivo Therapeutics Holdings Corp. (NVIV) compare to its historical average?